Cargando…

Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor

Therapies for lethal castration-resistant prostate cancer (CRPC) are an unmet medical need. One mechanism underlying CRPC and resistance to hormonal therapies is the expression of constitutively active splice variant(s) of androgen receptor (AR-Vs) that lack its C-terminus ligand-binding domain. Tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Jacky K., Imamura, Yusuke, Kato, Minoru, Wang, Jun, Mawji, Nasrin R., Sadar, Marianne D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985297/ https://www.ncbi.nlm.nih.gov/pubmed/33753863 http://dx.doi.org/10.1038/s42003-021-01927-3

Ejemplares similares

Differential Gene Expression Profiles between N-Terminal Domain and Ligand-Binding Domain Inhibitors of Androgen Receptor Reveal Ralaniten Induction of Metallothionein by a Mechanism Dependent on MTF1
por: Obst, Jon K., et al.
Publicado: (2022)

Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
por: Banuelos, Carmen A., et al.
Publicado: (2020)

SAT022 A Mechanism Of Resistance To Novel Inhibitors Of The N-Terminal Domain Of Androgen Receptor
por: Setiawan, Josie, et al.
Publicado: (2023)

Cyclin-dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogs for the Treatment of Androgen Receptor–positive Prostate and Breast Cancers
por: Tien, Amy H., et al.
Publicado: (2022)

Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain
por: Banuelos, Carmen A., et al.
Publicado: (2014)

Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
por: Banuelos, Carmen A., et al.
Publicado: (2016)

SAT023 The Role Of Cysteine Residues In The Binding Of Inhibitors Of The N-Terminal Domain Of The Androgen Receptor
por: Deneault, Lauren, et al.
Publicado: (2023)

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
por: Leung, Jacky K., et al.
Publicado: (2017)

Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
por: Imamura, Yusuke, et al.
Publicado: (2016)

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer
por: Myung, Jae-Kyung, et al.
Publicado: (2017)

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
por: Antonarakis, Emmanuel S., et al.
Publicado: (2016)

Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer
por: Hirayama, Yukiyoshi, et al.
Publicado: (2020)

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens
por: Ito, Yusuke, et al.
Publicado: (2018)

Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
por: Shimizu, Yasuomi, et al.
Publicado: (2018)

The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome
por: Schneider, Claudia, et al.
Publicado: (2009)

Structural study of MCPIP1 N-terminal conserved domain reveals a PIN-like RNase
por: Xu, Jiwei, et al.
Publicado: (2012)

Topological dynamics of an intrinsically disordered N‐terminal domain of the human androgen receptor
por: Sheikhhassani, Vahid, et al.
Publicado: (2022)

Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino‐terminal domain
por: Hua, Yaping, et al.
Publicado: (2018)

An Alternative Pin1 Binding and Isomerization Site in the N-Terminus Domain of PSD-95
por: Delgado, Jary Y.
Publicado: (2020)

FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells
por: Haile, Simon, et al.
Publicado: (2011)

Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
por: Ban, Fuqiang, et al.
Publicado: (2021)

A sting in the tail: the N-terminal domain of the androgen receptor as a drug target
por: Monaghan, Amy E, et al.
Publicado: (2016)

Structure of the homodimeric androgen receptor ligand-binding domain
por: Nadal, Marta, et al.
Publicado: (2017)

Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries
por: Romanuik, Tammy L, et al.
Publicado: (2009)

Definition of an N-terminal actin-binding domain and a C-terminal Ca2+ regulatory domain in human brevin
Publicado: (1986)

Non-catalytic participation of the Pin1 peptidyl-prolyl isomerase domain in target binding
por: Innes, Brendan T., et al.
Publicado: (2013)

Membrane Binding and Self-Association of the Epsin N-Terminal Homology Domain
por: Lai, Chun-Liang, et al.
Publicado: (2012)

Polarization of concave domains by traveling wave pinning
por: Bialecki, Slawomir, et al.
Publicado: (2017)

Comprehensive classification of the PIN domain-like superfamily
por: Matelska, Dorota, et al.
Publicado: (2017)

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium
por: Pal, Sumanta K., et al.
Publicado: (2019)

The C-terminus of p53 binds the N-terminal domain of MDM2
por: Poyurovsky, Masha V., et al.
Publicado: (2010)

Cellular and viral peptides bind multiple sites on the N‐terminal domain of clathrin
por: Muenzner, Julia, et al.
Publicado: (2016)

The structure of the C-terminal actin-binding domain of talin
por: Gingras, Alexandre R, et al.
Publicado: (2008)

An MBoC Favorite: Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site
por: Fehon, Richard
Publicado: (2012)

Mutation of Androgen Receptor N-Terminal Phosphorylation Site Tyr-267 Leads to Inhibition of Nuclear Translocation and DNA Binding
por: Karaca, Mehmet, et al.
Publicado: (2015)

Position-reconfigurable pinning for magnetic domain wall motion
por: Lee, Taekhyeon, et al.
Publicado: (2023)

Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors
por: McEwan, Iain J., et al.
Publicado: (2007)

Novel expressed sequences identified in a model of androgen independent prostate cancer
por: Quayle, Steven N, et al.
Publicado: (2007)

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin
Publicado: (1992)

Hepatoma derived growth factor binds DNA through the N-terminal PWWP domain
por: Yang, Jun, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_979md9669iemog9pl5gnoikhgq